Safety of hydroxychloroquine in healthcare workers for COVID-19 prophylaxis

BACKGROUND & OBJECTIVES: Hydroxychloroquine (HCQ), reported to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in in vitro studies, has been recommended for prophylaxis of COVID-19 in healthcare workers (HCWs). The objective of this study was to assess short-term...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Indian J Med Res
Main Authors: Faruqui, Atiya R., Xavier, Denis, Kamat, Sandhya K., Chandy, Sujith J., Medhi, Bikash, Tripathi, Raakhi K., Shetty, Yashashri C., Raj, John Michael, Kaushal, Sandeep, Balakrishnan, S., Atal, Shubham, Tripathi, Santanu K., Badyal, Dinesh K., Dikshit, Harihar, Roy, Sukalyan Saha, Trivedi, Niyati, Chatterjee, Suparna, Desai, Chetna, Tripathi, C.D., Rege, Nirmala N., Gupta, Pooja, Raveendran, R., Kaul, Rajni, Kshirsagar, Nilima A.
פורמט: Artigo
שפה:Inglês
יצא לאור: Wolters Kluwer - Medknow 2021
נושאים:
Programme
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC8184065/
https://ncbi.nlm.nih.gov/pubmed/33818480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijmr.IJMR_2294_20
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים